The University of Queensland, Brisbane, QLD, Australia.
School of Public Health, Faculty of Medicine, The University of Queensland, Herston Road, Herston, QLD, 4006, Australia.
BMC Cancer. 2020 Oct 6;20(1):963. doi: 10.1186/s12885-020-07454-4.
Healthy Living after Cancer (HLaC) was a national dissemination and implementation study of an evidence-based lifestyle intervention for cancer survivors. The program was imbedded into existing telephone cancer information and support services delivered by Australian state-based Cancer Councils (CC). We report here the reach, effectiveness, adoption, implementation, and maintenance of the program.
In this phase IV study (single-group, pre-post design) participants - survivors of any type of cancer, following treatment with curative intent - received up to 12 nurse/allied health professional-led telephone health coaching calls over 6 months. Intervention delivery was grounded in motivational interviewing, with emphasis on evidence-based behaviour change strategies. Using the RE-AIM evaluation framework, primary outcomes were reach, indicators of program adoption, implementation, costs and maintenance. Secondary (effectiveness) outcomes were participant-reported anthropometric, behavioural and psychosocial variables including: weight; physical activity; dietary intake; quality-of-life; treatment side-effects; distress; and fear of cancer recurrence and participant satisfaction. Changes were evaluated using linear mixed models, including terms for timepoint (0/6 months), strata (Cancer Council), and timepoint x strata.
Four of 5 CCs approached participated in the study. In total, 1183 cancer survivors were referred (mostly via calls to the Cancer Council telephone information service). Of these, 90.4% were eligible and 88.7% (n = 791) of those eligible consented to participate. Retention rate was 63.4%. Participants were mostly female (88%), aged 57 years and were overweight (BMI = 28.8 ± 6.5 kg/m2). Improvements in all participant-reported outcomes (standardised effect sizes of 0.1 to 0.6) were observed (p < 0.001). The program delivery costs were on average AU$427 (US$296) per referred cancer survivor.
This telephone-delivered lifestyle intervention, which was feasibly implemented by Cancer Councils, led to meaningful and statistically significant improvements in cancer survivors' health and quality-of-life at a relatively low cost.
Australian and New Zealand Clinical Trials Registry (ANZCTR) - ACTRN12615000882527 (registered on 24/08/2015).
癌症后的健康生活(HLaC)是一项全国范围内传播和实施的基于证据的生活方式干预计划,适用于癌症幸存者。该计划嵌入到澳大利亚州立癌症委员会(CC)提供的现有的电话癌症信息和支持服务中。我们在此报告该计划的覆盖范围、效果、采用、实施和维持情况。
在这项第四阶段研究(单组,前后设计)中,参与者 - 接受治愈性治疗的任何类型癌症的幸存者 - 在 6 个月内接受多达 12 次由护士/联合健康专业人员领导的电话健康指导。干预的提供基于动机访谈,重点是基于证据的行为改变策略。使用 RE-AIM 评估框架,主要结果是覆盖范围、计划采用指标、实施、成本和维持。次要(有效性)结果是参与者报告的人体测量、行为和心理社会变量,包括:体重;身体活动;饮食摄入;生活质量;治疗副作用;困扰;对癌症复发的恐惧和参与者满意度。使用线性混合模型评估变化,包括时间点(0/6 个月)、分层(癌症委员会)和时间点 x 分层的术语。
有 5 个 CC 中的 4 个参与了这项研究。共有 1183 名癌症幸存者被转介(主要是通过拨打癌症委员会电话信息服务)。其中,90.4%符合条件,符合条件的 88.7%(n=791)同意参与。保留率为 63.4%。参与者主要是女性(88%),年龄 57 岁,超重(BMI=28.8±6.5kg/m2)。所有参与者报告的结果均有改善(标准化效应大小为 0.1 至 0.6)(p<0.001)。该计划的交付成本平均为每位转介的癌症幸存者 427 澳元(306 美元)。
这项由癌症委员会实施的可行的电话生活方式干预措施,导致癌症幸存者的健康和生活质量有意义且具有统计学意义的改善,成本相对较低。
澳大利亚和新西兰临床试验注册中心(ANZCTR)- ACTRN12615000882527(于 2015 年 8 月 24 日注册)。